Metallothionein MT2A A-5G Polymorphism and the Risk for Chronic Kidney Disease and Diabetes

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan
来源：
TOXICOLOGICAL SCIENCES | 2016年 / 154卷 / 02期
关键词：
D O I：
10.1093/toxsci/kfw205
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [21] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [22] The phosphodiesterase inhibitor cilostazol reduced the risk of chronic kidney disease in type 2 diabetes without diabetic kidney disease
    Ahn, Y. -B.
    Yun, J. -S.
    Cha, S. -A.
    Ko, S. -H.
    Chang, S. -A.
    Son, H.
    Ko, S. -H.
    DIABETOLOGIA, 2017, 60 : S485 - S486
  • [23] Risk Factors for Progression of Chronic Kidney Disease in Individuals with Diabetes
    Maguire, Kaitlyn S.
    Woo, Vincent
    DIABETES, 2017, 66 : A595 - A595
  • [24] Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients
    Lovre, Dragana
    Shah, Sulay
    Sihota, Aanu
    Fonseca, Vivian A.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 237 - +
  • [25] Acute Kidney Injury Episodes and Chronic Kidney Disease Risk in Diabetes Mellitus
    Thakar, Charuhas V.
    Christianson, Annette
    Himmelfarb, Jonathan
    Leonard, Anthony C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (11): : 2567 - 2572
  • [26] Risk of Chronic Kidney Disease in Early-Onset Type 2 Diabetes in Mexico
    Silva-Tinoco, Ruben
    Cuatecontzi-Xochitiotzi, Teresa
    Guzman-Olvera, Eileen B.
    Delatorre-Saldana, Viridiana
    Galindez-Fuentes, Ana
    Castillo-Martinez, Lilia
    Bernal-Ceballos, Fernanda
    Rios-Carbajal, Vianey
    Torres-Sandoval, Narda
    Mejia-Vilet, Juan Manuel
    Ochoa-Moreno, Jorge
    Serna, Javier
    Lopez-Arellano, Oliva
    DIABETES, 2023, 72
  • [27] Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes
    Lou, Qing-Lin
    Ouyang, Xiao-Jun
    Gu, Liu-Bao
    Mo, Yong-Zhen
    Ma, Ronald
    Nan, Jennifer
    Kong, Alice
    So, Wing-Yee
    Ko, Gary
    Chan, Juliana
    Chow, Chun-Chung
    Bian, Rong-Wen
    DIABETES & METABOLISM JOURNAL, 2012, 36 (06) : 433 - 442
  • [28] In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor
    Agarwal, R.
    Pitt, B.
    Rossing, P.
    Anker, S. D.
    Filippatos, G.
    Ruilope, L. M.
    Kovesdy, C. P.
    Tuttle, K.
    Vaduganathan, M.
    Wanner, C.
    Bansilal, S.
    Gebel, M.
    Joseph, A.
    Lawatscheck, R.
    Bakris, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2420 - 2420
  • [29] Birthweight and risk of chronic kidney disease after being diagnosed with type 2 diabetes
    Hansen, A. L.
    Christiansen, C. F.
    Brons, C.
    Engelhard, L.
    Hansen, T.
    Nielsen, J. S.
    Vestergaard, P.
    Hojlund, K.
    Jessen, N.
    Olsen, M. H.
    Sorensen, H. T.
    Rossing, P.
    Thomsen, R.
    Vaag, A.
    DIABETOLOGIA, 2024, 67 : S147 - S147
  • [30] Excess of mortality risk in type 2 diabetes due to stage of chronic kidney disease
    Vikulova, O.
    Isakov, M.
    Zheleznyakova, A.
    Shamkhalova, M.
    Shestakova, M.
    Dedov, I.
    DIABETOLOGIA, 2019, 62 : S490 - S491
12345